Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
4
×
indiana top stories
life sciences
migraine
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
clinical trials
fda
lasmiditan
teva pharmaceutical
crispr
deals
fremanezumab
galcanezumab
gene therapy
What
bio
companies
new
roundup
approval
drug
drugs
life
science
arena’s
arguments
bails
big
biogen’s
biopharmaceutical
bounty
brand
bridgebio
capital
car
cig
class
comeback
commercialized
competitors
convo
corner
deals
decades
delivered
develop
earlier
emerges
expressing
failures
fda
firm
grab
headlines
ichnos
Language
unset
Current search:
migraine
×
biotech
×
" indiana blog main "
×
" eli lilly "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More